FOXL2-induced follistatin attenuates activin A-stimulated cell proliferation in human granulosa cell tumors

Biochemical and Biophysical Research Communications

Volumn 443, Issue 2, 2014, Pages 537-542

  Cheng, Jung Chien ^a   Chang, Hsun Ming ^a   Qiu, Xin ^a   Fang, Lanlan ^a   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Activin; Follistatin; FOXL2; Human granulosa cell tumors

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN A; CYCLIN D2; FOLLISTATIN; FORKHEAD BOX L2 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; MESSENGER RNA; SMAD PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GRANULOSA CELL TUMOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ACTIVIN; FOLLISTATIN; FOXL2; HUMAN GRANULOSA CELL TUMORS;

ACTIVINS; CELL PROLIFERATION; DOWN-REGULATION; FOLLISTATIN; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOSA CELL TUMOR; HUMANS;

EID: 84892442792     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.12.010     Document Type: Article

References (35)

1. J.F. Ethier, and J.K. Findlay Roles of activin and its signal transduction mechanisms in reproductive tissues Reproduction 121 2001 667 675
2. F. Miro, and S.G. Hillier Modulation of granulosa cell deoxyribonucleic acid synthesis and differentiation by activin Endocrinology 137 1996 464 468
3. J. Rabinovici, S.J. Spencer, and R.B. Jaffe Recombinant human activin-A promotes proliferation of human luteinized preovulatory granulosa cells in vitro J. Clin. Endocrinol. Metab. 71 1990 1396 1398
4. R.H. Young, and R.E. Scully Endocrine tumors of the ovary Curr. Top. Pathol. 85 1992 113 164
5. W. Zheng, C.J. Sung, I. Hanna, G. DePetris, G. Lambert-Messerlian, M. Steinhoff, and S.C. Lauchlan Alpha and beta subunits of inhibin/activin as sex cord-stromal differentiation markers Int. J. Gynecol. Pathol. 16 1997 263 271
6. P.J. Fuller, S. Chu, T. Jobling, P. Mamers, D.L. Healy, and H.G. Burger Inhibin subunit gene expression in ovarian cancer Gynecol. Oncol. 73 1999 273 279
7. R.E. Lappohn, H.G. Burger, J. Bouma, M. Bangah, M. Krans, and H.W. de Bruijn Inhibin as a marker for granulosa-cell tumors N. Engl. J. Med. 321 1989 790 793
8. M.M. Matzuk, M.J. Finegold, J.G. Su, A.J. Hsueh, and A. Bradley Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice Nature 360 1992 313 319
9. T. Shikone, M.M. Matzuk, E. Perlas, M.J. Finegold, K.A. Lewis, W. Vale, A. Bradley, and A.J. Hsueh Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor Mol. Endocrinol. 8 1994 983 995
10. J. Cocquet, E. Pailhoux, F. Jaubert, N. Servel, X. Xia, M. Pannetier, E. De Baere, L. Messiaen, C. Cotinot, M. Fellous, and R.A. Veitia Evolution and expression of FOXL2 J. Med. Genet. 39 2002 916 921
11. L. Crisponi, M. Deiana, A. Loi, F. Chiappe, M. Uda, P. Amati, L. Bisceglia, L. Zelante, R. Nagaraja, S. Porcu, M.S. Ristaldi, R. Marzella, M. Rocchi, M. Nicolino, A. Lienhardt-Roussie, A. Nivelon, A. Verloes, D. Schlessinger, P. Gasparini, D. Bonneau, A. Cao, and G. Pilia The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/ epicanthus inversus syndrome Nat. Genet. 27 2001 159 166
12. M.D. Pisarska, G. Barlow, and F.T. Kuo Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology Endocrinology 152 2011 1199 1208
13. S.P. Shah, M. Kobel, J. Senz, R.D. Morin, B.A. Clarke, K.C. Wiegand, G. Leung, A. Zayed, E. Mehl, S.E. Kalloger, M. Sun, R. Giuliany, E. Yorida, S. Jones, R. Varhol, K.D. Swenerton, D. Miller, P.B. Clement, C. Crane, J. Madore, D. Provencher, P. Leung, A. DeFazio, J. Khattra, G. Turashvili, Y. Zhao, T. Zeng, J.N. Glover, B. Vanderhyden, C. Zhao, C.A. Parkinson, M. Jimenez-Linan, D.D. Bowtell, A.M. Mes-Masson, J.D. Brenton, S.A. Aparicio, N. Boyd, M. Hirst, C.B. Gilks, M. Marra, and D.G. Huntsman Mutation of FOXL2 in granulosa-cell tumors of the ovary N. Engl. J. Med. 360 2009 2719 2729
14. T. Nakamura, K. Takio, Y. Eto, H. Shibai, K. Titani, and H. Sugino Activin-binding protein from rat ovary is follistatin Science 247 1990 836 838
15. J.P. de Winter, P. ten Dijke, C.J. de Vries, T.A. van Achterberg, H. Sugino, P. de Waele, D. Huylebroeck, K. Verschueren, and A.J. van den Eijnden-van Raaij Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors Mol. Cell. Endocrinol. 116 1996 105 114
16. A.L. Blount, K. Schmidt, N.J. Justice, W.W. Vale, W.H. Fischer, and L.M. Bilezikjian FoxL2 and Smad3 coordinately regulate follistatin gene transcription J. Biol. Chem. 284 2009 7631 7645
17. K.A. Schrader, B. Gorbatcheva, J. Senz, A. Heravi-Moussavi, N. Melnyk, C. Salamanca, S. Maines-Bandiera, S.L. Cooke, P. Leung, J.D. Brenton, C.B. Gilks, J. Monahan, and D.G. Huntsman The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors PLoS ONE 4 2009 e7988
18. Y. Nishi, T. Yanase, Y. Mu, K. Oba, I. Ichino, M. Saito, M. Nomura, C. Mukasa, T. Okabe, K. Goto, R. Takayanagi, Y. Kashimura, M. Haji, and H. Nawata Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor Endocrinology 142 2001 437 445
19. M.D. Pisarska, J. Bae, C. Klein, and A.J. Hsueh Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene Endocrinology 145 2004 3424 3433
20. J.C. Cheng, C. Klausen, and P.C. Leung Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors PLoS ONE 8 2013 e55099
21. G.J. Inman, F.J. Nicolas, J.F. Callahan, J.D. Harling, L.M. Gaster, A.D. Reith, N.J. Laping, and C.S. Hill SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 Mol. Pharmacol. 62 2002 65 74
22. T. Ogawa, K. Yogo, N. Ishida, and T. Takeya Synergistic effects of activin and FSH on hyperphosphorylation of Rb and G1/S transition in rat primary granulosa cells Mol. Cell. Endocrinol. 210 2003 31 38
23. Y. Abe, T. Minegishi, and P.C. Leung Activin receptor signaling Growth Factors 22 2004 105 110
24. S. Jamieson, and P.J. Fuller Molecular pathogenesis of granulosa cell tumors of the ovary Endocr. Rev. 33 2012 109 144
25. Y. Xia, and A.L. Schneyer The biology of activin: recent advances in structure, regulation and function J. Endocrinol. 202 2009 1 12
26. G.P. Risbridger, J.F. Schmitt, and D.M. Robertson Activins and inhibins in endocrine and other tumors Endocr. Rev. 22 2001 836 858
27. Y.G. Chen, Q. Wang, S.L. Lin, C.D. Chang, J. Chuang, and S.Y. Ying Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis Exp. Biol. Med. (Maywood) 231 2006 534 544
28. M.D. Steller, T.J. Shaw, B.C. Vanderhyden, and J.F. Ethier Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells Mol. Cancer Res. 3 2005 50 61
29. M.M. Matzuk, M.J. Finegold, J.P. Mather, L. Krummen, H. Lu, and A. Bradley Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice Proc. Natl. Acad. Sci. USA 91 1994 8817 8821
30. S.C. Cipriano, L. Chen, T.R. Kumar, and M.M. Matzuk Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice Endocrinology 141 2000 2319 2327
31. K.A. Coerver, T.K. Woodruff, M.J. Finegold, J. Mather, A. Bradley, and M.M. Matzuk Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice Mol. Endocrinol. 10 1996 534 543
32. Q. Li, R. Kumar, K. Underwood, A.E. O'Connor, K.L. Loveland, J.S. Seehra, and M.M. Matzuk Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein Mol. Hum. Reprod. 13 2007 675 683
33. K. Kashimada, E. Pelosi, H. Chen, D. Schlessinger, D. Wilhelm, and P. Koopman FOXL2 and BMP2 act cooperatively to regulate follistatin gene expression during ovarian development Endocrinology 152 2011 272 280
34. S. Jamieson, R. Butzow, N. Andersson, M. Alexiadis, L. Unkila-Kallio, M. Heikinheimo, P.J. Fuller, and M. Anttonen The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary Mod. Pathol. 23 2010 1477 1485
35. D. Nonis, K.J. McTavish, and S. Shimasaki Essential but differential role of FOXL2wt and FOXL2C134W in GDF-9 stimulation of follistatin transcription in co-operation with Smad3 in the human granulosa cell line COV434 Mol. Cell. Endocrinol. 372 2013 42 48